Breaking News

Thermo Fisher Expands Pharma Services Biz

Invests $150 million in sterile liquid and lyophilized product development and commercial manufacturing in Italy and Greenville, NC

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific Inc. is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing, in Monza and Ferentino, Italy, and Greenville, NC. The sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next two years. “These investments will help expand our global sterile manufacturing network and meet th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters